TILT Holdings (TLLTF) Shares Outstanding (Weighted Average) (2021 - 2025)

TILT Holdings (TLLTF) reported Shares Outstanding (Weighted Average) of $391.3 million for Q2 2025, up 1.07% on a YoY basis from $387.1 million in Q2 2024, and little changed quarter-over-quarter from $391.3 million in Q1 2025.

TILT Holdings (TLLTF) Shares Outstanding (Weighted Average) (2021 - 2025) Analysis & Trends

TILT Holdings has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $391.3 million in Q2 2025.

  • For the quarter ending Q2 2025, Shares Outstanding (Weighted Average) rose 1.07% year-over-year to $391.3 million; the trailing twelve-month figure through Jun 2025 stood at $391.3 million (up 1.07% YoY), and the FY2024 full-year result was $388.7 million, up 2.4% from the prior year.
  • Shares Outstanding (Weighted Average) for Q2 2025 stood at $391.3 million, roughly flat from $391.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $391.3 million in Q2 2025, with the low at $9.5 million in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $340.5 million across 5 years, with a median of $378.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) sank 87.08% — and 2023, when it surged 3876.43%.
  • TILT Holdings' Shares Outstanding (Weighted Average) stood at $73.9 million in 2021, then slumped by 87.08% to $9.5 million in 2022, then surged by 3876.43% to $379.6 million in 2023, then climbed by 2.4% to $388.7 million in 2024, then grew by 0.66% to $391.3 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $391.3 million (Q2 2025), $391.3 million (Q1 2025), and $388.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 TILT Holdings - - 1.82 Mn 391.26 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 391.26 Mn
Mar 31, 2025 391.25 Mn
Dec 31, 2024 388.71 Mn
Sep 30, 2024 387.92 Mn
Jun 30, 2024 387.10 Mn
Mar 31, 2024 385.72 Mn
Dec 31, 2023 379.58 Mn
Sep 30, 2023 378.54 Mn
Jun 30, 2023 378.30 Mn
Mar 31, 2023 377.70 Mn
Dec 31, 2022 9.55 Mn
Sep 30, 2022 375.31 Mn
Jun 30, 2022 375.54 Mn
Mar 31, 2022 374.61 Mn
Dec 31, 2021 73.91 Mn
Sep 30, 2021 371.06 Mn
Jun 30, 2021 361.64 Mn